Aclaris Therapeutics, Inc. (8AT.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
| Previous Close | 1.0840 |
| Open | 1.0280 |
| Bid | 1.0575 x 0 |
| Ask | 1.1050 x 0 |
| Day's Range | 1.0280 - 1.0280 |
| 52 Week Range | 0.5900 - 11.8450 |
| Volume | |
| Avg. Volume | 153 |
| Market Cap | 73.342M |
| Beta (5Y Monthly) | 0.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.7400 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 34.80 |
Simply Wall St.Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
A week ago, Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) came out with a strong set of second-quarter numbers that could...
Simply Wall St.Aclaris Therapeutics Second Quarter 2024 Earnings: Beats Expectations
Aclaris Therapeutics ( NASDAQ:ACRS ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.77m (up 48% from...
ZacksAclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
Aclaris (ACRS) delivered earnings and revenue surprises of 21.05% and 58.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.